iNtRON Biotechnology has announced the identification of Prophage and ORF-Jamphage from the microbiome frequently observed in long-term Pancreatic cancer survivors.
iNtRON Biotechnology has announced the identification of Prophage and ORF-Jamphage from the microbiome frequently observed in long-term Pancreatic cancer survivors.